Pranali Kerkar

National AIDS Research Institute

Papers

2

Total Citations

78

H-Index

2

About

Dr. Pranali Kerkar is a leading researcher in inhalation toxicology and advanced in vitro modeling, with a focus on addressing the urgent global health challenges posed by airborne pollutants and viral transmission. Her most impactful work, the 2021 paper "Emerging Technologies for In Vitro Inhalation Toxicology," has garnered 70 citations, establishing her as a key voice in the field. In this seminal review, Dr. Kerkar systematically evaluates the bottlenecks and potential of organ-on-a-chip systems, drawing on soft design processes to revolutionize how we study respiratory toxicology. Her contributions are particularly vital given that clinical and epidemiological research links air contamination to over 2 million annual morbidities worldwide. By critically analyzing the pros and cons of current technologies, she provides a roadmap for developing more predictive, human-relevant models that can accelerate drug testing and safety assessments. Dr. Kerkar’s work bridges cutting-edge bioengineering with pressing public health needs, making her a pivotal figure in the transition from traditional animal models to sophisticated in vitro platforms. Her research not only advances scientific understanding but also holds direct implications for mitigating the health impacts of inhaled hazards.

Research Focus

Key Achievements

2
H-Index
2
Papers
78
Total Citations
39
Avg Citations/Paper
🏆 Most Cited Paper
Emerging Technologies for In Vitro Inhalation Toxicology
70 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: National AIDS Research Institute

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago